Taking a Look at the Cognitive Assessment Disconnect
In the time that it takes to read the first few paragraphs of this column, someone in the United States will develop Alzheimer’s disease. ... Read more
Updates
-
-
ADvance II Study Testing Deep Brain Stimulation in Mild Alzheimer’s Started, Enrollment Ongoing
The first patient enrolled in the ADvance II Study has been implanted with a deep brain stimulation (DBS) device to start treatment for mild ... Read more -
Diet Directly Affects Gut Bacteria and May Contribute to Alzheimer’s Progression, Pilot Study Suggests
A modified Mediterranean-ketogenic diet can regulate bacteria in the gut that may contribute to the development and progression of cognitive impairment and Alzheimer’s disease, ... Read more -
ARPF Set to Host Brain Longevity Therapy Training and Symposium
With the goal of warding off Alzheimer’s disease through integrative medicine, the Alzheimer’s Research and Prevention Foundation (ARPF) will host its third Brain Longevity Therapy ... Read more -
Caregiver Preparation Is Key to Patient Care During a Catastrophe
At the time of this writing, all eyes are on the Eastern Seaboard of the United States in anticipation of Hurricane Dorian. The state ... Read more
-
TREM2 Protein May Slow Memory Impairment in Alzheimer’s, Study Suggests
Higher concentrations of a protein produced exclusively by the brain’s immune cells, called TREM2, ... -
ATXN1 Gene Tied to Rare Disorder Regulates Key Enzyme in Alzheimer’s
A gene associated with a rare balance disorder also may be involved in susceptibility ... -
Our Family’s Golden Retriever Is More Than Man’s Best Friend
This week, pet lovers across the United States celebrated National Dog Day to bring ... -
Understanding Protein Aggregation May Aid Quest for Better Alzheimer’s Treatments
Better understanding the mathematics behind how protein clumps form — and how therapies interfere ... -
Managing Caregiver Stress in AD Essential During Back-to-School Time, AFA Says
The strain of caring for someone with Alzheimer’s disease (AD) during the hectic back-to-school ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Anavex ‘Cautiously Optimistic’ After Noting Cognitive Improvement in Alzheimer’s Treatment
News
Anavex Life Sciences says its Alzheimer’s drug candidate Anavex 2-73 may have a role in treating the disease. Data from a long-term extension trial, although small, indicated that the therapy improved cognitive and functional measures in patients. According to data ... Read more